Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data

Objective To measure the effect on genital warts of the national human papillomavirus vaccination programme in Australia, which started in mid-2007.Design Trend analysis of national surveillance data.Setting Data collated from eight sexual health services from 2004 to 2011; the two largest clinics a...

Full description

Saved in:
Bibliographic Details
Published in:BMJ (Online) 2013-04, Vol.346 (7907), p.10-10
Main Authors: Ali, Hammad, Donovan, Basil, Wand, Handan, Read, Tim R H, Regan, David G, Grulich, Andrew E, Fairley, Christopher K, Guy, Rebecca J
Format: Article
Language:English
Subjects:
Adult
Age
Age groups
Australia - epidemiology
Children & youth
Condyloma acuminatum
Condylomata acuminata
Condylomata Acuminata - epidemiology
Condylomata Acuminata - prevention & control
Depopulation
Female
Health services
Herd immunity
Human papillomavirus
Humans
Male
Men
Mens health
Papillomaviridae - immunology
Papillomavirus Infections - epidemiology
Papillomavirus Infections - prevention & control
Papillomavirus Infections - virology
Papillomavirus vaccines
Papillomavirus Vaccines - administration & dosage
Program Evaluation
Retrospective Studies
Sexually transmitted diseases
STD
Surveillance
Trends
Vaccination
Vaccines
Warts
Womens health
Young Adult
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective To measure the effect on genital warts of the national human papillomavirus vaccination programme in Australia, which started in mid-2007.Design Trend analysis of national surveillance data.Setting Data collated from eight sexual health services from 2004 to 2011; the two largest clinics also collected self reported human papillomavirus vaccination status from 2009.Participants Between 2004 and 2011, 85 770 Australian born patients were seen for the first time; 7686 (9.0%) were found to have genital warts.Main outcome measure Rate ratios comparing trends in proportion of new patients diagnosed as having genital warts in the pre-vaccination period (2004 to mid-2007) and vaccination period (mid-2007 to the end of 2011).Results Large declines occurred in the proportions of under 21 year old (92.6%) and 21-30 year old (72.6%) women diagnosed as having genital warts in the vaccination period—from 11.5% in 2007 to 0.85% in 2011 (P
ISSN:0959-8138
1756-1833
1756-1833
DOI:10.1136/bmj.f2032